ARTICLE | Finance
Public equity report: IPOs for Kyverna, Metagenomi; 4D, Sana among follow-ons
Plus PIPEs for Adverum, Autolus, Mineralys, Silence, PepGen, Sensorion, Tenaya, Jasper and others
February 10, 2024 12:01 AM UTC
Updated on Feb 16, 2024 at 8:07 PM UTC
Two high-profile biotech listings landed on NASDAQ this week with mixed results in first-day trading, while public equity deals thrummed along in the form of follow-ons and PIPEs.
Healthy demand allowed Kyverna Therapeutics Inc. (NASDAQ:KYTX) to raise $319 million in an upsized IPO this week, with aftermarket activity suggesting the fulfillment of its underwriters’ option will further swell the company’s balance sheet...